High glucose enhances aggressiveness of EGFR-amplified non-small cell lung cancer via EGFR/STAT3 signaling pathway

被引：0
|
作者：
Sorin, Supannika [1 ,2 ]
Zhou, Yubin [3 ,4 ]
Pilamas, Urupong [1 ,2 ]
Wongkham, Sopit [1 ,2 ]
Saengboonmee, Charupong [1 ,2 ]
机构：
[1] Khon Kaen Univ, Dept Biochem, Fac Med, Khon Kaen, Thailand
[2] Khon Kaen Univ, Ctr Translat Med, Fac Med, Khon Kaen, Thailand
[3] Univ Elect Sci & Tech China, Thorac Surg, Chengdu, Peoples R China
[4] Chinese Acad Sci, Sichuan Translat Med Res Hosp, Beijing, Peoples R China
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1179
引用
收藏
页码：396 / 396
页数：1
相关论文
共 50 条
  • [41] HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer
    Yonesaka, Kimio
    Tanizak, Junko
    Maenishi, Osamu
    Haratani, Koji
    Kawakami, Hisato
    Tanaka, Kaoru
    Hayashi, Hidetoshi
    Sakai, Kazuko
    Chiba, Yasutaka
    Tsuya, Asuka
    Goto, Hiroki
    Otsuka, Eri
    Okida, Hiroaki
    Kobayashi, Maki
    Yoshimoto, Ryoto
    Funabashi, Masanori
    Hashimoto, Yuuri
    Hirotani, Kenji
    Kagari, Takashi
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    CLINICAL CANCER RESEARCH, 2022, 28 (02) : 390 - 403
  • [42] Correlation of EGFR Del 19 with Fn14/JAK/STAT signaling molecules in non-small cell lung cancer
    Sun, Ying
    Han, Yong
    Wang, Xiaoping
    Wang, Wuping
    Wang, Xuejiao
    Wen, Miaomiao
    Xia, Jinghua
    Xing, Hao
    Li, Xiaofei
    Zhang, Zhipei
    ONCOLOGY REPORTS, 2016, 36 (02) : 1030 - 1040
  • [43] Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in non-small cell lung cancer A549 cells via the JAK/STAT3 signaling pathway
    Zhang, Tingxiu
    Ma, Lijie
    Wu, Pengfei
    Li, Wei
    Li, Ting
    Gu, Rui
    Dan, Xiaoping
    Li, Zhiwei
    Fan, Xianming
    Xiao, Zhenliang
    ONCOLOGY REPORTS, 2019, 41 (03) : 1779 - 1788
  • [44] STAT3 gene polymorphisms and susceptibility to non-small cell lung cancer
    Jiang, B.
    Zhu, Z. Z.
    Liu, F.
    Yang, L. J.
    Zhang, W. Y.
    Yuan, H. H.
    Wang, J. G.
    Hu, X. H.
    Huang, G.
    GENETICS AND MOLECULAR RESEARCH, 2011, 10 (03) : 1856 - 1865
  • [45] EGFR mutation and p-EGFR expression in resected Non-Small Cell Lung Cancer
    Liu Wei
    McMillen, Elizabeth
    Ye Fei
    Li Guanghu
    Wu Yong
    Yin Guanghao
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S916 - S916
  • [46] Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyond
    Delaney, Christopher
    Frank, Samuel
    Huang, R. Stephanie
    CHINESE JOURNAL OF CANCER, 2015, 34
  • [47] Prognostic value of EGFR genotype in EGFR-mutant non-small cell lung cancer
    Syrigos, Konstantinos
    Kotteas, Ilias
    Paraskeva, Maria
    Gkiozos, Ioannis
    Boura, Paraskevi
    Tsagouli, Sofia
    Grapsa, Dimitra
    Charpidou, Andriani
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [48] EGFR Signaling in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Opportunities
    La Monica, Silvia
    CELLS, 2022, 11 (08)
  • [49] ASSESSMENT OF EGFR, VEGFR, AND SELECTED DOWNSTREAM SIGNALING MOLECULES IN NON-SMALL CELL LUNG CANCER
    Xu, Zhaolin
    Bethune, Drew
    Yan, Sen R.
    Huang, Weei
    Bethune, Gillian
    Dewar, Ron
    Ridgway, Neale
    Johnston, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1018 - S1018
  • [50] Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer
    Hosokawa, Shinobu
    Toyooka, Shinichi
    Fujiwara, Yoshiro
    Tokumo, Masaki
    Soh, Junichi
    Takigawa, Nagio
    Hotta, Katsuyuki
    Yoshino, Tadashi
    Date, Hiroshi
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    LUNG CANCER, 2009, 66 (01) : 107 - 113
12345